HHS Makes Significant Changes to COVID-19 Daily Data Reporting Process

NHSN COVID-19 Reporting Module Being Retired as of Wednesday, July 15

The Department of Health and Human Services (HHS) today announced significant changes to the process for hospitals to fulfill the agency’s request for daily data reporting on bed capacity, utilization, personal protective equipment (PPE) and in-house laboratory testing data. The most significant changes are detailed below.

Reporting Options. The Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) COVID-19 module will no longer be an option for daily data reporting as of July 15. Hospitals are asked to use one of the other reporting options to fulfill the data reporting request, including:

  • Reporting data to their state health departments, provided that their states have assumed responsibility for reporting hospital data to HHS. Such states have written authorization from their Assistant Secretary for Preparedness and Response (ASPR) regional administrator that they are assuming data reporting responsibilities. In turn, states should provide hospitals with written notification they are submitting data to HHS on their behalf.
     
  • Report to the HHS TeleTracking portal, an existing option for daily reporting. The TeleTracking portal also has been used for special data reporting requests related to high-impact funds distribution, as well as remdesivir distribution. For issues with accessing the TeleTracking portal or questions about the data, contact TeleTracking Technical Support at 1-877-570-6903.

Data Fields. HHS has made significant updates to the data fields it is asking for in daily reporting. For example, HHS is asking for information on both pediatric and adult patients, and is asking hospitals for information about their inventory of remdesivir.

The AHA strongly urges all hospitals to review the announcement and report the data to HHS as requested. HHS stressed in the announcement the importance of reporting the requested data on a daily basis to inform the Administration’s ongoing response to the pandemic, including the allocation of supplies, treatments and other resources. In addition, the agency notes it will no longer ask for one-time requests for data to aid in the distribution of remdesivir or any other treatments or supplies. This means that the daily reporting is the only mechanism used for the distribution calculations

Related Resources

Letter/Comment
Public
The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services 200 Independence Avenue, S.W., Room 445-G Washington, DC 20201…
Action Alert
Member
The Provider Relief Fund Deadline Extension Act (S. 2493/H.R. 4735) was introduced yesterday in the Senate and House.
Special Bulletin
Member
The Senate last night voted 67-32 to move forward on a roughly $1 trillion bipartisan infrastructure package. A bipartisan group of senators and the White…
Advancing Health Podcast
Public
Communities of color, who over the past year have been disproportionately affected by the COVID-19 pandemic, also experienced emotional distress exacerbated by…
Letter/Comment
Public
The AHA tells Senate leaders it strongly opposes “any attempt to take away previously-appropriated funding for hospitals and health systems, physicians, nurses…
Other Resources
Public
Fighting an “avoidable surge” in COVID-19 cases, the CEO and care teams at CoxHealth share stats and stories to urge their Southwest Missouri community to get…